201
Participants
Start Date
October 10, 2017
Primary Completion Date
April 21, 2020
Study Completion Date
April 21, 2020
CS02 tablet and placebo tablet
Subjects receive CS02 tablet or placebo tablet BID daily with a stable dose of metformin monotherapy of ≥ 1500 mg/day for 12 weeks treatment.
Tri-Service General Hospital, Taipei
Chang Gung Memorial Hospital_Linkou, Taoyuan District
Chung Shan Medical University Hospital, Taichung
China Medical University Hospital, Taichung
Chi-Mei Medical Center, Tainan City
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
National Taiwan University Hospital, Taipei
Taipei Veterans general Hospital, Taipei
The Community Research of South Florida, Hialeah
Clinical Research of South Florida, Coral Gables
Taichung Veterans General Hospital, Taichung
Applied Research Center of Arkansas, Inc., Little Rock
Kaohsiung Veterans General Hospital, Kaohsiung City
Lead Sponsor
Center Laboratories, Inc.
INDUSTRY